In people with diabetes, insulin aspart (IAsp) (NovoRapid, Novo Nordisk, Denmark) is more rapidly absorbed than regular human insulin (RHI), with higher maximal concentration and shorter time to peak concentration.1–3 However, total absorption, the area under the concentration–time curve, is similar for IAsp and RHI. Here, INS is linked to diabetes mellitus.